# BENZYL ALCOHOL

URL: https://app.greenveil.ai/ingredients/ingredient_cas_100_51_6
Categories: beauty, cleaning, industrial, pharma
Functions: preservative, Biocide, Deodorizer, Emulsifier, Flavouring and nutrient, Fragrance, Pharmaceutical, Preservative, Solvent, Viscosity modifier, epoxy resin coatings, lacquers, paints
Identifier: 100-51-6

> BENZYL ALCOHOL is used as preservative / biocide. Greenveil chemical-concern score: 70/100 — High concern based on regulatory listings.. Assessed from 58 sources.

## Safety assessment

- Chemical concern score: 70/100 — High concern based on regulatory listings.
- Confidence: 4
- Rationale: Benzyl Alcohol is restricted in cosmetic products under Annex III of the EU Cosmetics Regulation (EC) 1223/2009.

## Regulatory status

- EU: restricted — Annex III of EU Cosmetics Regulation (EC) 1223/2009: substances which cosmetic products must not contain except subject to the restrictions laid down. Product types: (a) Solvent (b) Fragrance/ aromatic compositions/ their raw materials Other conditions: For purposes other than inhibiting the development of microorganisms in the product. This purpose has to be apparent from the presentation of the product. The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds: — 0,001 % in leave-on products — 0,01 % in rinse-off products.
- EU: allowed_listed — Annex V of EU Cosmetics Regulation (EC) 1223/2009: preservatives allowed in cosmetic products. Maximum concentration: 1.0%
- US: commercial use observed — EPA CPDat observed this chemical in 9929 composition records across product categories including Raw materials, Industrial products, Construction. EPA CPDat classifies this chemical for functional uses including Preservative, Solvent, Fragrance.
- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SUSPENSION; Potency: 0.9 %w/v
- US: inactive ingredient database — Route: ENDOTRACHEAL; Dosage form: INJECTION; Maximum daily exposure: 54 mg
- US: inactive ingredient database — Route: INTRA-ARTERIAL; Dosage form: INJECTION; Potency: 0.9 %w/v
- US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION; Potency: 1 %w/v
- US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 23 mg
- US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 40 mg
- US: inactive ingredient database — Route: INTRACAVERNOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 18 mg
- US: inactive ingredient database — Route: INTRACAVITARY; Dosage form: INJECTION; Potency: 0.01 ml
- US: inactive ingredient database — Route: INTRACAVITARY; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 8.4 mg
- US: inactive ingredient database — Route: INTRALESIONAL; Dosage form: INJECTION; Maximum daily exposure: 23 mg
- US: inactive ingredient database — Route: INTRALESIONAL; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 20 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 1000 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, EMULSION; Maximum daily exposure: 225 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 144 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 500 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 40 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: SOLUTION; Maximum daily exposure: 54 mg
- US: inactive ingredient database — Route: INTRASYNOVIAL; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 18 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 1620 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, EMULSION; Maximum daily exposure: 45 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 144 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 400 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: LIQUID; Potency: 1.04 %w/v
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: SOLUTION; Maximum daily exposure: 242 mg
- US: inactive ingredient database — Route: NASAL; Dosage form: SPRAY; Maximum daily exposure: 5 mg
- US: inactive ingredient database — Route: NASAL; Dosage form: SPRAY, METERED; Potency: 5 mg/1ml
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 450 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Potency: 1.23 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 360 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 100 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Potency: 1.06 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 2.31 mg
- US: inactive ingredient database — Route: RECTAL; Dosage form: GEL; Maximum daily exposure: 124 mg
- US: inactive ingredient database — Route: RECTAL; Dosage form: SUPPOSITORY; Potency: 129 mg
- US: inactive ingredient database — Route: SOFT TISSUE; Dosage form: INJECTION; Maximum daily exposure: 23 mg
- US: inactive ingredient database — Route: SOFT TISSUE; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 40 mg
- US: inactive ingredient database — Route: SUBCONJUNCTIVAL; Dosage form: INJECTION; Maximum daily exposure: 252 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Maximum daily exposure: 90 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, EMULSION; Maximum daily exposure: 225 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Potency: 0.95 %w/v
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 160 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 185 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: LOTION; Maximum daily exposure: 4000 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: OINTMENT; Potency: 2.2 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SHAMPOO; Potency: 1.25 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SOLUTION; Potency: 2 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SUSPENSION; Potency: 1 %w/w
- US: inactive ingredient database — Route: VAGINAL; Dosage form: CREAM; Potency: 1 %w/w
- US: inactive ingredient database — Route: VAGINAL; Dosage form: GEL; Maximum daily exposure: 100 mg
- US: inactive ingredient database — Route: VAGINAL; Dosage form: SUPPOSITORY; Potency: NA
- US: marketed drug occurrence — FDA NDC lists this ingredient in 24 active drug products and 29 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.

_Assessed by Greenveil._